无创双水平气道正压通气治疗重症社区获得性肺炎疗效分析.docVIP

无创双水平气道正压通气治疗重症社区获得性肺炎疗效分析 　　[摘要] 目的 探讨无创双水平气道正压通气（BiPAP）治疗重症社区获得性肺炎的临床疗效。 方法 分析我院自2012年1月～2014年1月收治的82例SCAP患者，82例患者随机分为治疗组（42例）与对照组（40例）。对照组给予常规治疗，包括抗感染，祛痰，抗休克，扩张支气管，维持水电解质酸碱平衡以及营养支持。治疗组在对照组的基础上，给予无创双水平气道正压通气治疗。观察两组患者的临床疗效、气血水平以及临床症状。 结果 对照组与治疗组临床总有效率分别为82.50%（33/40）、 95.24%（40/42），两组比较差异且有统计学意义（P0.05）；治疗后治疗组在咳嗽、发热、肺部??音、白细胞计数方面，显著低于对照组，两组比较有统计学意义（P0.05）。 结论 无创双水平气道正压通气治疗SCAP，可以提高临床总有效率，有效改善临床症状及气血水平，有临床推广应用的价值。 　　[关键词] 重症社区获得性肺炎；无创双水平气道正压通气；疗效；症状；不良反应 　　[中图分类号] R563.1 [文献标识码] B [文章编号] 2095-0616（2015）11-193-03 　　[Abstract] Objective To investigate the clinical curative effect of Bilevel positive airway pressure （BiPAP） in the treatment of severe community acquired pneumonia （SCAP）. Methods 82 cases of SCAP patients in our hospital from 2012 January to 2014 January were analyzed and randomly divided into treatment group （42 cases） and control group （40 cases）. The control group received conventional therapy， including anti infection， eliminating phlegm， anti shock， bronchiectasis， maintenance the balance of fluid， electrolytes and acid-base， nutritional support. The treatment group was given BiPAP based on the treatment in control group. The clinical curative effect， the blood level and the clinical symptoms of two groups of patients were observed. Results The total clinical effective rates in two groups were 82.50% （33/40）， 95.24% （40/42），there was statistically significant （P0.05）； The cough， fever， pulmonary rales and white blood cell count in the treatment group after treatment were significantly lower than the control group， there were statistically significant （P0.05）. Conclusion BiPAP in the treatment of SCAP， can improve the total clinical efficiency， effectively improve the clinical symptoms and blood level， has clinical application value. 　　[Key words] Severe community acquired pneumonia； Bilevel positive airway pressure； Curative effect； Symptoms； Adverse reaction 　　重症社区获得性肺炎（severe community-acquired pneumonia，SCAP）是呼吸系统的常见病，进行通气治疗即可有效缓解危重期合并呼吸